These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10351813)

  • 21. Inflation frustration. Higher prices for raw materials have begun to hit the cost of health products, and GPOs are feeling the pressure.
    Rhea S
    Mod Healthc; 2008 Sep; 38(35):S1-5. PubMed ID: 18792596
    [No Abstract]   [Full Text] [Related]  

  • 22. As layoffs hit, Baxter tools for growth.
    Wagner M
    Mod Healthc; 1990 Mar; 20(10):4. PubMed ID: 10103896
    [No Abstract]   [Full Text] [Related]  

  • 23. Big two's control of market to change supply industry.
    Scott L
    Mod Healthc; 1994 Feb; 24(9):45-6. PubMed ID: 10131997
    [No Abstract]   [Full Text] [Related]  

  • 24. HME groups discuss merger.
    Lutz S; Wagner M
    Mod Healthc; 1991 Mar; 21(10):17. PubMed ID: 10109613
    [No Abstract]   [Full Text] [Related]  

  • 25. Baxter initiatives aim to give growing non-hospital business more liberty to go its own way.
    Wagner M
    Mod Healthc; 1992 May; 22(18):6. PubMed ID: 10117610
    [No Abstract]   [Full Text] [Related]  

  • 26. 2 Baxter heads exit, restructuring continues.
    Scott L; Japsen B
    Mod Healthc; 1994 Jan; 24(1):3. PubMed ID: 10130657
    [No Abstract]   [Full Text] [Related]  

  • 27. Churning things up.
    Grove A
    Fortune; 2003 Aug; 148(3):114-6, 118. PubMed ID: 12931387
    [No Abstract]   [Full Text] [Related]  

  • 28. Building a powerhouse. Novation fills executive ranks, begins bidding process.
    Hensley S
    Mod Healthc; 1998 Apr; 28(17):36. PubMed ID: 10179161
    [No Abstract]   [Full Text] [Related]  

  • 29. Baxter's changes may benefit hospitals.
    Scott L
    Mod Healthc; 1993 Sep; 23(37):2. PubMed ID: 10128183
    [No Abstract]   [Full Text] [Related]  

  • 30. IVAX set to acquire McGaw in $40 million stock swap.
    Scott L
    Mod Healthc; 1994 Jan; 24(2):2. PubMed ID: 10130890
    [No Abstract]   [Full Text] [Related]  

  • 31. And then there were three. With consolidation leaving three major players in each sector of the medical device industry, what happens to competition?
    Becker C
    Mod Healthc; 2005 May; 35(20):6-7, 12, 1. PubMed ID: 15926359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacy distributors' nod to med-surg seen as helpful.
    DeJohn P
    Hosp Mater Manage; 1998 Feb; 23(2):1, 10-1. PubMed ID: 10179100
    [No Abstract]   [Full Text] [Related]  

  • 33. Variety of factors hobble supply industry.
    Scott L
    Mod Healthc; 1993 Aug; 23(31):9. PubMed ID: 10127406
    [No Abstract]   [Full Text] [Related]  

  • 34. Baxter defines restructuring plans.
    Scott L
    Mod Healthc; 1993 Nov; 23(47):3. PubMed ID: 10129934
    [No Abstract]   [Full Text] [Related]  

  • 35. Network of laws governs resale of products.
    Holthaus D
    Hospitals; 1988 Sep; 62(18):54. PubMed ID: 3410444
    [No Abstract]   [Full Text] [Related]  

  • 36. Owens & Minor, Stuart Medical don't foresee merger challenge.
    Scott L
    Mod Healthc; 1994 Jan; 24(1):10. PubMed ID: 10130644
    [No Abstract]   [Full Text] [Related]  

  • 37. Product suppliers in the new managed care environment. Interview by David Cassak.
    Thompson K
    Health Ind Today; 1987 Apr; 50(4):24-36, 38-42. PubMed ID: 10283102
    [No Abstract]   [Full Text] [Related]  

  • 38. J&J's purchase of Cordis to provide marketing edge.
    Scott L
    Mod Healthc; 1995 Nov; 25(46):25. PubMed ID: 10152182
    [No Abstract]   [Full Text] [Related]  

  • 39. Hillenbrand ponders split.
    Mantone J
    Mod Healthc; 2006 Nov; 36(44):17. PubMed ID: 17128946
    [No Abstract]   [Full Text] [Related]  

  • 40. Revenge of the GPOs.
    Haugh R
    Hosp Health Netw; 2001 Apr; 75(4):60-2, 64. PubMed ID: 11330139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.